The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy

International Journal of Hyperthermia

Volumn 22, Issue 4, 2006, Pages 287-299

  Masunaga, Shin Ichiro ^a   Nagasawa, Hideko ^b   Sakurai, Yoshinori ^a   Uto, Yoshihiro ^b   Hori, Hitoshi ^b   Nagata, Kenji ^a   Suzuki, Minoru ^a   Maruhashi, Akira ^a   Kinashi, Yuko ^a   Ono, Koji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Boron neutron capture therapy; Hypoxic cytotoxin; Quiescent cell; Sodium borocaptate 10B; Thermal neutrons

Indexed keywords

3 AMINO 2 QUINOXALINECARBONITRILE 1,4 DIOXIDE; BOROCAPTATE; BORON 10; BROXURIDINE; CYTOCHALASIN B; DRUG CARRIER; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LABELING; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG MUSCLE LEVEL; DRUG STRUCTURE; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; FEMALE; GAMMA SPECTROMETRY; HYPERTHERMIC THERAPY; HYPOXIA; IMMUNOFLUORESCENCE; INCUBATION TIME; MICRONUCLEUS; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; RADIOSENSITIZATION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR CELL;

ANIMALS; ANOXIA; BOROHYDRIDES; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELL SURVIVAL; COMBINED MODALITY THERAPY; CYCLIC N-OXIDES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HYPERTHERMIA, INDUCED; MICE; MICE, INBRED C3H; MICRONUCLEUS TESTS; QUINOXALINES; QUINUCLIDINES; SULFHYDRYL COMPOUNDS; TIME FACTORS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 33745097466     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730600708171     Document Type: Article

References (23)

1. Barth, RF and Coderre, JA and Vicente, MGH and Blue, TE. (2005) Boron neutron capture therapy of cancer: Current status and future prospects Clin Cancer Res, 11, pp. 3987-4002.
2. Masunaga, S and Ono, K. (2002) Significance of the response of quiescent cell populations within solid tumors in cancer therapy J Radiat Res, 43, pp. 11-25.
3. Nagasawa, H and Yamashita, M and Mikamo, N and Shimamura, M and Oka, S and Uto, Y and Hori, H. (2002) Design, synthesis and biological activities of antiangiogenic hypoxic cytotoxin, triazine-N-oxide derivatives Comp Biochem Physiol A Mol Integr Physiol, 132, pp. 33-40.
4. Griffin, RJ and Okajima, K and Ogawa, A and Song, CW. (1999) Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing Int J Radiat Biol, 75, pp. 1299-1306.
5. Masunaga, S and Ono, K and Hori, H and Kinashi, Y and Suzuki, M and Takagaki, M and Kasai, S and Nagasawa, H and Uto, Y. (1999) Modification of tirapazamine-induced cytotoxicity in combination with mild Hyperthermia and/or nicotinamide: Reference to effect on quiescent tumour cells Int J Hyperthermia, 15, pp. 7-16.
6. Masunaga, S and Ono, K and Suzuki, M and Takagaki, M and Sakurai, Y and Kobayashi, T and Akuta, K and Akaboshi, M and Kinashi, Y and Abe, M. (1997) Modification of the response of a quiescent cell population with a murine solid tumour to boron neutron capture irradiation: Studies with nicotinamide and hyperthermia Br J Radiol, 70, pp. 391-398.
7. Masunaga, S and Nagasawa, H and Gotoh, K and Sakurai, Y and Uto, Y and Hori, H and Nagata, K and Suzuki, M and Maruhashi, A and Kinashi, Y and Ono, K. (2006) Evaluation of hypoxia-specific bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy Radiat Med, 24, pp. 98-107.
8. Hori, H and Jin, C-Z and Kiyono, M and Shimamura, M and Inayama, S. (1997) Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacrtylcarbamoyl-2-nitroimidazoles Bioorg Med Chem, 5, pp. 591-599.
9. Kobayashi, T and Kanda, K. (1983) Microanalysis system of ppm-order 10B concentrations in tissue for neutron capture therapy by prompt γ-ray spectrometry Nucl Instrum Meth, 204, pp. 525-531.
10. Nishimura, Y and Ono, K and Hiraoka, M and Masunaga, S and Jo, S and Shibamoto, Y and Sasai, K and Abe, M and Iga, K and Ogawa, Y. (1990) Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin Radiat Res, 122, pp. 161-167.
11. Caswell, RS and Coyne, JJ and Randolph, ML. (1980) Kerma factors for neutron energies below 30 MeV. Radiat Res, 83, pp. 217-254.
12. Sakurai, Y and Kobayashi, T. (2000) Characteristics of the KUR heavy water neutron irradiation facility as a neutron irradiation field with variable energy spectra Nucl Instr Meth Phys Res A, 453, pp. 569-596.
13. Brown, JM. (2000) Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies Mol Med Today, 6, pp. 157-162.
14. Masunaga, S and Ono, K and Sakurai, Y and Takagaki, M and Kobayashi, T and Suzuki, M and Kinashi, Y and Akaboshi, M. (1998) Response of quiescent and total tumor cells in solid tumors to neutrons with various cadmium ratios Int J Radiat Oncol Biol Phys, 41, pp. 1163-1170.
15. Masunaga, S and Ono, K and Akaboshi, M and Nishimura, Y and Suzuki, M and Kinashi, Y and Takagaki, M and Hiraoka, M and Abe, M. (1997) Reduction of hypoxic cells in solid tumours induced by mild hyperthermia: Special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations Br J Cancer, 7, pp. 588-593.
16. Song, CW and Park, HJ and Griffin, RJ. (2001) Improvement of tumor oxygenation by mild hyperthermia Radiat Res, 155, pp. 515-528.
17. Song, CW and Park, HJ and Lee, CK and Griffin, RJ. (2005) Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment Int J Hyperthermia, 21, pp. 761-767.
18. Maruyama, K and Ishida, O and Kasaoka, S and Takizawa, T and Utoguchi, N and Shinohara, A and Chiba, M and Kobayashi, H and Eriguchi, M and Yanagie, H. (2004) Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT) J Control Rel, 98, pp. 195-207.
19. Masunaga, S and Ono, K and Suzuki, M and Kinashi, Y and Takagaki, M and Hori, H and Kasai, S and Nagasawa, H and Uto, Y. (2000) Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures-reference to the effect on intratumor quiescent cells Jpn J Cancer Res, 91, pp. 566-572.
20. Masunaga, S and Nagasawa, H and Uto, Y and Hori, H and Suzuki, M and Nagata, K and Kinashi, Y and Ono, K. (2005) The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumor cell populations Int J Hyperthermia, 21, pp. 305-318.
21. Vaupel, P and Kelleher, DK and Hoeckel, M. (2001) Oxygenation status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy Semin Oncol, 28(Suppl 8), pp. 29-35.
22. Masunaga, S and Ono, K and Abe, M. (1993) The detection and modification of the hypoxic fraction in quiescent cell populations in murine solid tumors Br J Radiol, 66, pp. 918-926.
23. Brown, JM and Giaccia, AJ. (1998) The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy Cancer Res, 58, pp. 1408-1416.